ARCC upgraded to Buy by UBS; stock near 18.53 as availability of shares to borrow rises to 37.4%, easing short squeeze risk.
Key data as of 5 Nov 2026
ARCC upgraded to Buy by UBS; stock near 18.53 as availability of shares to borrow rises to 37.4%, easing short squeeze risk.
Ares Capital Corporation faces a sharply constrained lending market. Every share available to borrow has been lent out — and short interest has climbed 35% in a single month. Availability on ARCC has collapsed to near…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARCC — free to start on ORTEX.
Sign up for free →Open ARCC on ORTEX